The Technical Analyst
Select Language :
Constellation [CNST]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Constellation Price, Forecast, Insider, Ratings, Fundamentals & Signals

Constellation is listed at the  Exchange

0.00% $33.99

America/New_York / 31 des 1970 @ 19:00


RATING 2021-07-15
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/191/202/203/204/201/21
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 33.26 - 34.72

( +/- 2.16%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2021-07-15 Hoerter Steven L. Sell 26 342 Stock Option (right to buy)
2021-07-15 Reeve Emma Sell 60 000 Stock Option (Right to Buy)
2021-07-15 Reeve Emma Sell 37 527 Stock Option (right to buy)
2021-07-15 Reeve Emma Sell 73 428 Stock Option (right to buy)
2021-07-15 Reeve Emma Sell 11 777 Stock Option (right to buy)
INSIDER POWER
0.00
Last 99 transactions
Buy: 291 157 | Sell: 1 004 317

Forecast: 01:40 - $30.40

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $33.99 (0.00% )
Volume 1.269 mill
Avg. Vol. 1.573 mill
% of Avg. Vol 80.68 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Constellation Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Constellation Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for Constellation Pharmaceuticals, Inc.

Last 10 Buy & Sell Signals For CNST

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Constellation Pharmaceuticals, Inc.

CNST

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Its lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. The company is also developing CPI-0209 that is in Phase I dose escalation portion of a Phase I/II clinical trial to treat solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
QLYSMar 28 - 13:42$166.23
TTWOMar 28 - 13:41$148.60
KAVAUSDMar 28 - 13:41$0.994
XMONUSDMar 28 - 13:39902.51
POOLXUSDMar 28 - 13:395.36
SLMMar 28 - 13:37$21.77
PARAMar 28 - 13:36$11.79
GTMar 28 - 13:36$13.78
GEHCMar 28 - 13:3690.62
HTHTMar 28 - 13:36CNY38.37

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.